Anzeige
Mehr »
Login
Dienstag, 24.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DU6V | ISIN: US1897631057 | Ticker-Symbol: C97
Tradegate
23.12.24
08:00 Uhr
0,685 Euro
-0,015
-2,14 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CO-DIAGNOSTICS INC Chart 1 Jahr
5-Tage-Chart
CO-DIAGNOSTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,6800,72023.12.
0,6800,72023.12.

Aktuelle News zur CO-DIAGNOSTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.12.Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges3
05.12.Co-Diagnostics-Aktie erreicht 52-Wochen-Tief bei 0,85 US-Dollar2
05.12.Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges2
25.11.Co-Diagnostics-Aktie erreicht 52-Wochen-Tief bei 1 US-Dollar-
25.11.Co-Diagnostics stock hits 52-week low at $1 amid market challenges1
CO-DIAGNOSTICS Aktie jetzt für 0€ handeln
07.11.Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results65SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
07.11.Co-Diagnostics, Inc. - 10-Q, Quarterly Report-
07.11.Co-Diagnostics, Inc. - 8-K, Current Report-
06.11.Co-Diagnostics Q3 2024 Earnings Preview1
31.08.Co-Diagnostics sees shareholder backing in annual meeting votes3
30.08.Co-Diagnostics, Inc. - 8-K, Current Report1
13.08.Co-Diagnostics stock target cut by H.C. Wainwright13
08.08.Co-Diagnostics, Inc. - 10-Q, Quarterly Report1
08.08.Co-Diagnostics, Inc. - 8-K, Current Report1
08.08.Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Results176SALT LAKE CITY, August 8, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
09.05.Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results810SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development...
► Artikel lesen
14.03.Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results1.135SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
► Artikel lesen
07.03.Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test375The clinical laboratory real-time PCR multiplex test was designed using Co-Dx Co-Primers and licensed by the CDSCO for use in diagnostic procedures SALT LAKE CITY, March 7, 2024 /PRNewswire/ --...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1